John Poyhonen
2021 - Heron Therapeutics
In 2021, John Poyhonen earned a total compensation of $1.8M as President and Chief Commercial Officer at Heron Therapeutics, a 31% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $203,899 |
|---|---|
| Option Awards | $535,147 |
| Salary | $509,748 |
| Stock Awards | $583,626 |
| Other | $8,700 |
| Total | $1,841,120 |
Poyhonen received $583.6K in stock awards, accounting for 32% of the total pay in 2021.
Poyhonen also received $203.9K in non-equity incentive plan, $535.1K in option awards, $509.7K in salary and $8.7K in other compensation.
Rankings
In 2021, John Poyhonen's compensation ranked 6,368th out of 12,415 executives tracked by ExecPay. In other words, Poyhonen earned more than 48.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,368 out of 12,415 | 49th |
Division Manufacturing | 2,716 out of 5,508 | 51st |
Major group Chemicals And Allied Products | 1,195 out of 2,378 | 50th |
Industry group Drugs | 1,063 out of 2,099 | 49th |
Industry Pharmaceutical Preparations | 768 out of 1,549 | 50th |
Pay ratio
| John Poyhonen's Pay | $1,841,120 |
|---|---|
| Median Employee's Pay | $268,692 |
| Pay Ratio | 7to 1 |
In 2021, the annual total compensation of John Poyhonen was $1,841,120.
The annual total compensation of the median employee at Heron Therapeutics was $268,692.
The ratio of John Poyhonen's pay to the pay of median employee was therefore 7 to one.
Source: SEC filing on April 25, 2022.
Poyhonen's colleagues
We found four more compensation records of executives who worked with John Poyhonen at Heron Therapeutics in 2021.